| 1 | success | 10,946 |
| 2 | resectability | 127 |
| 3 | normalcy | 33 |
| 4 | success/failure | 22 |
| 5 | drop-off | 13 |
| 6 | failure/relapse | 9 |
| 7 | cephalea | 5 |
| 8 | ipos | 5 |
| 9 | relapse-recurrence | 5 |
| 10 | survival/success | 5 |
| 11 | group/responder | 4 |
| 12 | negative-turning | 4 |
| 13 | retearing | 4 |
| 14 | canceration | 3 |
| 15 | hss+ | 3 |
| 16 | 'take-home-baby | 2 |
| 17 | bracket-failure | 2 |
| 18 | correct-answer | 2 |
| 19 | cure-improvement | 2 |
| 20 | extraction/hydrolysis | 2 |
| 21 | failure/mortality | 2 |
| 22 | igfbp-3sds | 2 |
| 23 | incompletion | 2 |
| 24 | left-without-being-seen | 2 |
| 25 | mono-ovulatory | 2 |
| 26 | needlesticks | 2 |
| 27 | re-thoracotomy | 2 |
| 28 | re-treatment-free | 2 |
| 29 | redo-pvr | 2 |
| 30 | relapse/reinfection | 2 |
| 31 | reoperation-free | 2 |
| 32 | seop | 2 |
| 33 | standard-reaching | 2 |
| 34 | stroke/mortality | 2 |
| 35 | transnegative | 2 |
| 36 | vaccine-efficacy | 2 |
| 37 | 'concordance | 1 |
| 38 | 4-day-service | 1 |
| 39 | 5-yr-survival | 1 |
| 40 | anti-gii.4-positive | 1 |
| 41 | back-at-work | 1 |
| 42 | blastocyst-formation | 1 |
| 43 | cardiac-complication | 1 |
| 44 | cerivastatin-reporting | 1 |
| 45 | coronary-event | 1 |
| 46 | cured-effective | 1 |
| 47 | data.evidence | 1 |
| 48 | dialysis-dgf | 1 |
| 49 | disease-controlled | 1 |
| 50 | electron-hopping | 1 |
| 51 | eosinophil-suppression | 1 |
| 52 | experimentwise-error | 1 |
| 53 | fitment | 1 |
| 54 | glitch | 1 |
| 55 | hci-production | 1 |
| 56 | hrt1/2 | 1 |
| 57 | hydrolysis-fasculation | 1 |
| 58 | karvonen/heart | 1 |
| 59 | low-digestion | 1 |
| 60 | major-cri | 1 |
| 61 | mass-loss | 1 |
| 62 | mesh-protrusion | 1 |
| 63 | moderate-digestion | 1 |
| 64 | mono-ovulation | 1 |
| 65 | no-ip | 1 |
| 66 | not-inconsequential | 1 |
| 67 | nutrient-consumption | 1 |
| 68 | objective-response | 1 |
| 69 | one-survival | 1 |
| 70 | photo-transformation | 1 |
| 71 | photodecomposition | 1 |
| 72 | polymerization-conversion | 1 |
| 73 | positive-screen | 1 |
| 74 | pre-prophylaxis | 1 |
| 75 | procedure-success | 1 |
| 76 | rates/discontinuation | 1 |
| 77 | re-participation | 1 |
| 78 | recannalization | 1 |
| 79 | reionization | 1 |
| 80 | relapse/re-infection | 1 |
| 81 | revurrence | 1 |
| 82 | rncr-free | 1 |
| 83 | screening-to-randomisation | 1 |
| 84 | self-citation | 1 |
| 85 | spironolactone-prescription | 1 |
| 86 | st/heart | 1 |
| 87 | t-pa/pai-2 | 1 |
| 88 | tendon-healing | 1 |
| 89 | three-survival | 1 |
| 90 | treatment-completion | 1 |
| 91 | treatmentfailure | 1 |
| 92 | virological-failure | 1 |
| 1 | 'concordance | 1 |
| 2 | 'take-home-baby | 2 |
| 3 | 4-day-service | 1 |
| 4 | 5-yr-survival | 1 |
| 5 | anti-gii.4-positive | 1 |
| 6 | back-at-work | 1 |
| 7 | blastocyst-formation | 1 |
| 8 | bracket-failure | 2 |
| 9 | canceration | 3 |
| 10 | cardiac-complication | 1 |
| 11 | cephalea | 5 |
| 12 | cerivastatin-reporting | 1 |
| 13 | coronary-event | 1 |
| 14 | correct-answer | 2 |
| 15 | cure-improvement | 2 |
| 16 | cured-effective | 1 |
| 17 | data.evidence | 1 |
| 18 | dialysis-dgf | 1 |
| 19 | disease-controlled | 1 |
| 20 | drop-off | 13 |
| 21 | electron-hopping | 1 |
| 22 | eosinophil-suppression | 1 |
| 23 | experimentwise-error | 1 |
| 24 | extraction/hydrolysis | 2 |
| 25 | failure/mortality | 2 |
| 26 | failure/relapse | 9 |
| 27 | fitment | 1 |
| 28 | glitch | 1 |
| 29 | group/responder | 4 |
| 30 | hci-production | 1 |
| 31 | hrt1/2 | 1 |
| 32 | hss+ | 3 |
| 33 | hydrolysis-fasculation | 1 |
| 34 | igfbp-3sds | 2 |
| 35 | incompletion | 2 |
| 36 | ipos | 5 |
| 37 | karvonen/heart | 1 |
| 38 | left-without-being-seen | 2 |
| 39 | low-digestion | 1 |
| 40 | major-cri | 1 |
| 41 | mass-loss | 1 |
| 42 | mesh-protrusion | 1 |
| 43 | moderate-digestion | 1 |
| 44 | mono-ovulation | 1 |
| 45 | mono-ovulatory | 2 |
| 46 | needlesticks | 2 |
| 47 | negative-turning | 4 |
| 48 | no-ip | 1 |
| 49 | normalcy | 33 |
| 50 | not-inconsequential | 1 |
| 51 | nutrient-consumption | 1 |
| 52 | objective-response | 1 |
| 53 | one-survival | 1 |
| 54 | photo-transformation | 1 |
| 55 | photodecomposition | 1 |
| 56 | polymerization-conversion | 1 |
| 57 | positive-screen | 1 |
| 58 | pre-prophylaxis | 1 |
| 59 | procedure-success | 1 |
| 60 | rates/discontinuation | 1 |
| 61 | re-participation | 1 |
| 62 | re-thoracotomy | 2 |
| 63 | re-treatment-free | 2 |
| 64 | recannalization | 1 |
| 65 | redo-pvr | 2 |
| 66 | reionization | 1 |
| 67 | relapse-recurrence | 5 |
| 68 | relapse/re-infection | 1 |
| 69 | relapse/reinfection | 2 |
| 70 | reoperation-free | 2 |
| 71 | resectability | 127 |
| 72 | retearing | 4 |
| 73 | revurrence | 1 |
| 74 | rncr-free | 1 |
| 75 | screening-to-randomisation | 1 |
| 76 | self-citation | 1 |
| 77 | seop | 2 |
| 78 | spironolactone-prescription | 1 |
| 79 | st/heart | 1 |
| 80 | standard-reaching | 2 |
| 81 | stroke/mortality | 2 |
| 82 | success | 10,946 |
| 83 | success/failure | 22 |
| 84 | survival/success | 5 |
| 85 | t-pa/pai-2 | 1 |
| 86 | tendon-healing | 1 |
| 87 | three-survival | 1 |
| 88 | transnegative | 2 |
| 89 | treatment-completion | 1 |
| 90 | treatmentfailure | 1 |
| 91 | vaccine-efficacy | 2 |
| 92 | virological-failure | 1 |
| 1 | hss+ | 3 |
| 2 | t-pa/pai-2 | 1 |
| 3 | hrt1/2 | 1 |
| 4 | cephalea | 5 |
| 5 | disease-controlled | 1 |
| 6 | 4-day-service | 1 |
| 7 | 'concordance | 1 |
| 8 | data.evidence | 1 |
| 9 | relapse-recurrence | 5 |
| 10 | revurrence | 1 |
| 11 | reoperation-free | 2 |
| 12 | rncr-free | 1 |
| 13 | re-treatment-free | 2 |
| 14 | virological-failure | 1 |
| 15 | bracket-failure | 2 |
| 16 | success/failure | 22 |
| 17 | treatmentfailure | 1 |
| 18 | objective-response | 1 |
| 19 | failure/relapse | 9 |
| 20 | transnegative | 2 |
| 21 | cured-effective | 1 |
| 22 | anti-gii.4-positive | 1 |
| 23 | drop-off | 13 |
| 24 | dialysis-dgf | 1 |
| 25 | standard-reaching | 2 |
| 26 | tendon-healing | 1 |
| 27 | negative-turning | 4 |
| 28 | electron-hopping | 1 |
| 29 | retearing | 4 |
| 30 | cerivastatin-reporting | 1 |
| 31 | glitch | 1 |
| 32 | major-cri | 1 |
| 33 | back-at-work | 1 |
| 34 | not-inconsequential | 1 |
| 35 | three-survival | 1 |
| 36 | one-survival | 1 |
| 37 | 5-yr-survival | 1 |
| 38 | positive-screen | 1 |
| 39 | left-without-being-seen | 2 |
| 40 | polymerization-conversion | 1 |
| 41 | eosinophil-suppression | 1 |
| 42 | mesh-protrusion | 1 |
| 43 | cardiac-complication | 1 |
| 44 | hydrolysis-fasculation | 1 |
| 45 | mono-ovulation | 1 |
| 46 | blastocyst-formation | 1 |
| 47 | photo-transformation | 1 |
| 48 | re-participation | 1 |
| 49 | canceration | 3 |
| 50 | screening-to-randomisation | 1 |
| 51 | self-citation | 1 |
| 52 | rates/discontinuation | 1 |
| 53 | recannalization | 1 |
| 54 | reionization | 1 |
| 55 | relapse/re-infection | 1 |
| 56 | relapse/reinfection | 2 |
| 57 | hci-production | 1 |
| 58 | treatment-completion | 1 |
| 59 | incompletion | 2 |
| 60 | photodecomposition | 1 |
| 61 | spironolactone-prescription | 1 |
| 62 | nutrient-consumption | 1 |
| 63 | moderate-digestion | 1 |
| 64 | low-digestion | 1 |
| 65 | no-ip | 1 |
| 66 | seop | 2 |
| 67 | group/responder | 4 |
| 68 | correct-answer | 2 |
| 69 | experimentwise-error | 1 |
| 70 | redo-pvr | 2 |
| 71 | igfbp-3sds | 2 |
| 72 | extraction/hydrolysis | 2 |
| 73 | pre-prophylaxis | 1 |
| 74 | needlesticks | 2 |
| 75 | ipos | 5 |
| 76 | success | 10,946 |
| 77 | procedure-success | 1 |
| 78 | survival/success | 5 |
| 79 | mass-loss | 1 |
| 80 | cure-improvement | 2 |
| 81 | fitment | 1 |
| 82 | coronary-event | 1 |
| 83 | karvonen/heart | 1 |
| 84 | st/heart | 1 |
| 85 | 'take-home-baby | 2 |
| 86 | vaccine-efficacy | 2 |
| 87 | normalcy | 33 |
| 88 | re-thoracotomy | 2 |
| 89 | mono-ovulatory | 2 |
| 90 | stroke/mortality | 2 |
| 91 | failure/mortality | 2 |
| 92 | resectability | 127 |